4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population QPORTM platform delivers unprecedented predictive insights for patients with low immune infiltrates–achieving a 66% response rate vs. 25% with conventional methods GlobeNewswire June 02, 2025 NEWTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) — […]